| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 3328719 | Critical Reviews in Oncology/Hematology | 2014 | 10 Pages | 
Abstract
												The current management of locally advanced breast cancer (LABC) is based on tri-modality treatment including chemotherapy, radiotherapy and surgery. The concept of preoperative concurrent or sequential chemoradiation for LABC was initially reported more than a decade ago; however this concept did not gain popularity because of the low benefit/risk ratio and the lack of strong data supporting the concept. The purpose of the current systematic review was to explore the published data about preoperative chemoradiation (sequential and/or concurrent) using whole breast irradiation in terms of toxicity and outcome.
Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Hematology
												
											Authors
												Orit Kaidar-Person, Abraham Kuten, Yazid Belkacemi, 
											